Search results
Found 16156 matches for
Adjusting to daily life with social isolation and lockdown has its challenges and the dramatic situation that we find ourselves in because of the COVID-19 pandemic, means people with eating disorders are at risk of their disorder becoming more severe or relapsing.
SINAPPS2 Background & PPiP2 Recruitment Training Confirmation
The SINAPPS2 Trial is inviting people with acute psychosis symptom(s) and anti-neuronal membrane antibodies who have been identified through PPiP2 study to consent the trial and help testing the efficacy and safety of immunotherapy for antibody-associated psychosis.